Last reviewed · How we verify
progenipoietin — Competitive Intelligence Brief
discontinued
Other
Biologic
Live · refreshed every 30 min
Target snapshot
progenipoietin (progenipoietin) — University of Southern California.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| progenipoietin TARGET | progenipoietin | University of Southern California | discontinued |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- progenipoietin CI watch — RSS
- progenipoietin CI watch — Atom
- progenipoietin CI watch — JSON
- progenipoietin alone — RSS
Cite this brief
Drug Landscape (2026). progenipoietin — Competitive Intelligence Brief. https://druglandscape.com/ci/progenipoietin. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing